Methyltetrazine-amido-PEG5-alkyne

What We Offer

Methyltetrazine-amido-PEG5-alkyne

Methyltetrazine-amido-PEG5-alkyne | 2322322-23-4

Catelog Number R08-0034
Category Tetrazines
Molecular Formula C₂₄H₃₃N₅O₆
Molecular Weight 487.55
Catalog Number Size Price Quantity
R08-0034 -- $--

Product Introduction

Methyltetrazine-amido-PEG5-alkyne is a polyethylene glycol (PEG)-based PROTAC linker. Methyltetrazine-amido-PEG5-alkyne can be used in the synthesis of a series of PROTACs.

Chemical Information

Synonyms Methyltetrazine-amido-PEG5-alkyne; N-(4-(6-Methyl-1,2,4,5-tetrazin-3-yl)benzyl)-4,7,10,13,16-pentaoxanonadec-18-ynamide; N-{[4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl]methyl}-4,7,10,13,16-pentaoxanonadec-18-ynamide
Purity 98%
IUPAC Name N-[[4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl]methyl]-3-[2-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethoxy]ethoxy]propanamide
Canonical SMILES CC1=NN=C(N=N1)C2=CC=C(C=C2)CNC(=O)CCOCCOCCOCCOCCOCC#C
InChI InChI=1S/C24H33N5O6/c1-3-9-31-11-13-33-15-17-35-18-16-34-14-12-32-10-8-23(30)25-19-21-4-6-22(7-5-21)24-28-26-20(2)27-29-24/h1,4-7H,8-19H2,2H3,(H,25,30)
InChI Key OHZFOEAHYKQSRL-UHFFFAOYSA-N
Solubility DMSO, DCM, DMF

Product Specification

Storage Please store the product under the recommended conditions in the Certificate of Analysis.

Computed Properties

XLogP3 -0.9
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 10
Rotatable Bond Count 19
Exact Mass 487.24308379 g/mol
Monoisotopic Mass 487.24308379 g/mol
Topological Polar Surface Area 127Ų
Heavy Atom Count 35
Formal Charge 0
Complexity 588
Isotope Atom Count 0
Defined Atom Stereocenter Count 0
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
Covalently-Bonded Unit Count 1
Compound Is Canonicalized Yes

Patents

Publication NumberTitlePriority Date
US-2016120987-A1 Chemical structures for localized delivery of therapeutic agents 2013-06-19
US-2019111140-A1 Chemical structures for localized delivery of therapeutic agents 2013-06-19
US-10953098-B2 Chemical structures for localized delivery of therapeutic agents 2013-06-19
cartIcon
Inquiry Basket